Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Hyperhomocysteinemia prevalence among patients with venous thromboembolism
R Ben Salah1, M Boudaya2, S Fendri2
1Department of internal medicine, Faculty of Medicine, University of SFAX, Sfax, Tunisia.
Insights
Elevated plasma homocysteine (Hcy) levels and hyperhomocysteinemia (HHC) are significantly more prevalent in Tunisian deep vein thrombosis (DVT) patients compared to healthy individuals. This suggests HHC is a risk factor for DVT.
Area of Science:
- Cardiovascular Research
- Clinical Biochemistry
- Thrombosis and Hemostasis
Background:
- Hyperhomocysteinemia (HHC), characterized by elevated plasma homocysteine (Hcy) levels, is increasingly recognized as a potential risk factor for venous thromboembolism.
- Deep Vein Thrombosis (DVT) is a significant health concern, and understanding its associated risk factors is crucial for effective prevention and management.
Purpose of the Study:
- To investigate plasma homocysteine levels and the prevalence of hyperhomocysteinemia in Tunisian patients diagnosed with deep vein thrombosis.
- To compare these findings with a control group of healthy individuals to establish a potential association between HHC and DVT in this population.
Main Methods:
- An observational case-control study was conducted.
- Plasma homocysteine (Hcy) levels were measured in hospitalized patients with unprovoked DVT and compared to healthy controls.
- Levels of vitamin B12 and B9 were also determined, given their role in homocysteine metabolism.
Main Results:
- Mean plasma homocysteine levels were significantly higher in DVT patients compared to controls.
- The prevalence of hyperhomocysteinemia was markedly elevated in DVT patients (61.7%) versus controls (4%).
- Hyperhomocysteinemia was associated with a 3.54-fold increased risk of developing DVT.
Conclusions:
- This study demonstrates a strong association between elevated homocysteine levels and deep vein thrombosis in the studied Tunisian population.
- Hyperhomocysteinemia is a prevalent condition and a significant risk factor for DVT.
Aims:
The objectives of this study were to determine the plasma homocysteine (Hcy) levels and the prevalence of Hyperhomocysteinemia (HHC) in a group of Tunisian patients with deep vein thrombosis (DVT) by comparing it with healthy controls.
Methods:
it was an observational case-control study including patients hospitalized for the management of unprovoked DVT. For each subject, a routine biochemical assay was conducted, including plasma homocysteine measurement and determination of vitamin B12 and B9 levels, as these vitamins are essential for assessing hyperhomocysteinemia in DVT patients due to their role in regulating homocysteine.
Results:
We observed an increased mean plasma Hcy level compared to controls and the prevalence of Hyperhomocysteinemia 61.7% against 4% in the control subjects. The risk of developing DVT with HHC is 3.54.
Conclusion:
Our study found that homocysteine levels were higher in patients with DVT than in controls.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Esophageal Varices-I: Introduction

